Under pathological conditions such as diabetes and myocardial ischemia, insulin signal transduction pathways, such as phosphatidylinositol 3-kinase/protein kinase B (Akt) signaling, are clearly modified [25,26]. This evidence concerns the gene INS and myocardial ischemia.